Suh CO - Search Results

1

Modern Radiation Therapy for Extranodal Nasal-Type NK/T-cell Lymphoma: Risk-Adapted Therapy, Target Volume, and Dose Guidelines from the International Lymphoma Radiation Oncology Group.

Qi SN, Li YX, Specht L, Oguchi M, Tsang R, Ng A, Suh CO, Ricardi U, Mac Manus M, Dabaja B, Yahalom J. Qi SN, et al. Among authors: suh co. Int J Radiat Oncol Biol Phys. 2021 Jul 15;110(4):1064-1081. doi: 10.1016/j.ijrobp.2021.02.011. Epub 2021 Feb 11. Int J Radiat Oncol Biol Phys. 2021. PMID: 33581262 Review.

2

Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.

Lee SW, Suh CO, Chung EJ, Kim GE. Lee SW, et al. Among authors: suh co. Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1338-44. doi: 10.1016/s0360-3016(01)02821-8. Int J Radiat Oncol Biol Phys. 2002. PMID: 11955747

3

Role of radiotherapy for primary orbital lymphoma.

Lee SW, Suh CO, Kim GE, Yang WI, Lee SY, Hahn JS, Park JO. Lee SW, et al. Among authors: suh co. Am J Clin Oncol. 2002 Jun;25(3):261-5. doi: 10.1097/00000421-200206000-00011. Am J Clin Oncol. 2002. PMID: 12040284

4

Dose-response relationship in local radiotherapy for hepatocellular carcinoma.

Park HC, Seong J, Han KH, Chon CY, Moon YM, Suh CO. Park HC, et al. Among authors: suh co. Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):150-5. doi: 10.1016/s0360-3016(02)02864-x. Int J Radiat Oncol Biol Phys. 2002. PMID: 12182985

5

Rationale for radiotherapy as a treatment modality in gastric mucosa-associated lymphoid tissue lymphoma.

Park W, Chang SK, Yang WI, Ko YH, Huh SJ, Ahn YC, Suh CO. Park W, et al. Among authors: suh co. Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1480-6. doi: 10.1016/j.ijrobp.2003.09.002. Int J Radiat Oncol Biol Phys. 2004. PMID: 15050327

6

Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpoints.

Koom WS, Chung EJ, Yang WI, Shim SJ, Suh CO, Roh JK, Yoon JH, Kim GE. Koom WS, et al. Among authors: suh co. Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1127-37. doi: 10.1016/j.ijrobp.2003.12.006. Int J Radiat Oncol Biol Phys. 2004. PMID: 15234048

7

Coexpression of cyclooxygenase-2 and thymidine phosphorylase as a prognostic indicator in patients with FIGO stage IIB squamous cell carcinoma of uterine cervix treated with radiotherapy and concurrent chemotherapy.

Pyo H, Kim YB, Cho NH, Suh CO, Park TK, Yun YS, Kim GE. Pyo H, et al. Among authors: suh co. Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):725-32. doi: 10.1016/j.ijrobp.2004.10.044. Int J Radiat Oncol Biol Phys. 2005. PMID: 15936552

8

Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior.

Suh CO, Shim SJ, Lee SW, Yang WI, Lee SY, Hahn JS. Suh CO, et al. Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):228-33. doi: 10.1016/j.ijrobp.2005.11.035. Epub 2006 Feb 28. Int J Radiat Oncol Biol Phys. 2006. PMID: 16503386

9

Clinical significance of cyclooxygenase-2 expression in extranodal natural killer (NK)/T-cell lymphoma, nasal type.

Shim SJ, Yang WI, Shin E, Koom WS, Kim YB, Cho JH, Suh CO, Kim JH, Kim GE. Shim SJ, et al. Among authors: suh co. Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):31-8. doi: 10.1016/j.ijrobp.2006.07.1387. Epub 2006 Oct 16. Int J Radiat Oncol Biol Phys. 2007. PMID: 17049184

10

Clinical significance of margin status in postoperative radiotherapy for extremity and truncal soft-tissue sarcoma.

Kim YB, Shin KH, Seong J, Roh JK, Kim GE, Hahn SB, Suh CO. Kim YB, et al. Among authors: suh co. Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):139-44. doi: 10.1016/j.ijrobp.2007.05.067. Epub 2007 Oct 24. Int J Radiat Oncol Biol Phys. 2008. PMID: 17919843

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

220 results

Search Page